Target intelligence / Profile preview

Ubiquinol-cytochrome c reductase binding protein (UQCRB)

Target
UQCRB
Molecular classification
Mitochondrial respiratory chain complex subunit, Electron transport chain protein, Other (specifically, subunit of ubiquinol-cytochrome c oxidoreductase/Complex III/Cytochrome bc1 complex)
01

Overview

Ubiquinol-cytochrome c reductase binding protein (UQCRB) is a nuclear-encoded, approximately 14 kDa subunit of mitochondrial complex III (ubiquinol-cytochrome c oxidoreductase, cytochrome bc1 complex), integral to the mitochondrial respiratory chain. UQCRB binds ubiquinone and participates directly in the electron transport process, stabilizing mitochondrial complex III and supporting cellular oxygen sensing and hypoxia-induced angiogenesis via regulation of mitochondrial reactive oxygen species production. UQCRB is essential for mitochondrial energy generation and is implicated in mitochondrial diseases (notably complex III deficiency), various cancers, and cardiovascular disorders. UQCRB's expression and genetic variation serve as biomarkers in oncology and mitochondrial pathology, and it is a target for anti-angiogenic therapies, though therapeutic inhibition is limited by the risk of mitochondrial dysfunction and associated systemic toxicity[1][2][3][4].

Other names
Complex III subunit 7QP-CUbiquinol-cytochrome c reductase complex 14 kDa proteinQCR7UQBPUQCR6QPCMC3DN3Complex III subunit VIICytochrome b-c1 complex subunit 7
02

Mechanism of action

Inhibition of UQCRB disrupts electron transfer in complex III, suppressing mROS generation and downstream angiogenesis Modulation of UQCRB disrupts tumor cell metabolism and mitochondrial function

03

Biological functions

Electron transport in mitochondrial respiratory chainMaintenance of mitochondrial complex III stabilityCellular oxygen sensingRegulation of angiogenesis (especially hypoxia-induced)Generation of mitochondrial reactive oxygen species (mROS)
04

Disease associations

Mitochondrial complex III deficiencyCancer (notably colorectal cancer and glioblastoma)Mitochondrial encephalomyopathiesCardiomyopathyProgressive exercise intoleranceOther multisystem mitochondrial diseases (e.g., deafness, retinitis pigmentosa, epilepsy)Cardiovascular disease (via role in cardiac regeneration)
05

Safety considerations

Inhibition leads to mitochondrial dysfunction, resulting in severe side effects such as lactic acidosis, hypoglycemia, encephalopathy, cardiomyopathy, and multisystem disorders due to deficient energy productionComplex III deficiency has highly heterogeneous and potentially life-threatening phenotypes
06

Interacting drugs

Terpestacin (natural anti-angiogenic small molecule)

1 more in the full profile.

07

Biomarkers

UQCRB gene expression (upregulated in colorectal cancer, correlates with disease stage)UQCRB copy number variation (amplification in tumor tissue)UQCRB protein level (prognostic for colorectal cancer and possibly other malignancies)Polymorphisms and methylation status of UQCRB may be relevant for disease prediction and diagnosis

Beyond the preview

Go deeper on Ubiquinol-cytochrome c reductase binding protein (UQCRB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquinol-cytochrome c reductase binding protein (UQCRB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call